{"id":"NCT00791999","sponsor":"Otsuka Pharmaceutical Co., Ltd.","briefTitle":"Efficacy Confirmation Trial of CDP870 as add-on Medication to Methotrexate (MTX) in Japanese Rheumatoid Arthritis (RA)","officialTitle":"A Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Assess the Efficacy, Pharmacokinetics and Safety of CDP870 as add-on Medication to MTX in Japanese Active RA Patients Who Have an Incomplete Response to MTX.","status":"COMPLETED","phase":"PHASE2","dates":{"start":"2008-11","primaryCompletion":"2010-01","completion":"2011-01","firstPosted":"2008-11-17","resultsPosted":"2012-08-06","lastUpdate":"2012-08-10"},"enrollment":316,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Rheumatoid Arthritis"],"interventions":[{"type":"DRUG","name":"CDP870 400mg","otherNames":[]},{"type":"DRUG","name":"CDP870 200mg","otherNames":[]},{"type":"DRUG","name":"CDP870 100mg","otherNames":[]},{"type":"DRUG","name":"Placebo of CDP870","otherNames":[]}],"arms":[{"label":"CDP870 100mg","type":"EXPERIMENTAL"},{"label":"CDP870 200mg","type":"EXPERIMENTAL"},{"label":"CDP870 400mg","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"The objective of this trial is to investigate the efficacy (American College of Rheumatology 20% : ACR20) superiority of two dose regiments of CDP870 versus placebo in combination with MTX in active RA patients who have an incomplete response to MTX. The pharmacokinetics and immunogenicity profile of CDP870 will also be investigated to assess the extrapolability of foreign data to the Japanese population.","primaryOutcome":{"measure":"American College of Rheumatology 20% (ACR20) Response at Week 12","timeFrame":"Baseline, Week 12","effectByArm":[{"arm":"CDP870 100mg","deltaMin":62.5,"sd":null},{"arm":"CDP870 200mg","deltaMin":76.8,"sd":null},{"arm":"CDP870 400mg","deltaMin":77.6,"sd":null},{"arm":"Placebo","deltaMin":28.6,"sd":null}],"pValues":[{"comp":"OG000 vs OG001 vs OG002","p":"<0.025"}]},"eligibility":{"minAge":"20 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":3,"exclusionCount":9},"locations":{"siteCount":8,"countries":["Japan"]},"refs":{"pmids":["24313916"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":3,"n":72},"commonTop":["Nasopharyngitis","Hepatic function abnormal","Rheumatoid arthritis","Pharyngitis","Upper respiratory tract infection"]}}